America Great Health
AAGH - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.23M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $4.23 Million |
|---|---|
| Enterprise Value | $7.34 Million |
| Earnings per Share | $0 |
| Beta | 6.41 |
| Outstanding Shares | 21,152,711,608 |
Return
| Return on Equity | -13.27% |
|---|---|
| Return on Assets | 381.07% |
| Return on Invested Capital | -56.65% |
Valuation & Multiples
| P/E Ratio | 2 |
|---|---|
| PEG | 40.53 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 20.2 |
| Enterprise Value to EBIT | 5.27 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.43 |
| Debt to Equity | -0.65 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About America Great Health
5 employees
CEO: Mike Qingkun Wang
Operating as a U.S.-based biotechnology company, America Great Health (AAGH) focuses on two primary areas: the research and development of protein and peptide small molecular drugs, and the manufacturing and sale of a diverse portfolio i...